Journal of Viral Hepatitis

Papers
(The H4-Index of Journal of Viral Hepatitis is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Issue Information42
240‐week entecavir maleate treatment in Chinese chronic hepatitis B predominantly genotype B or C40
Prevalence and characteristics of hepatitis C virus infection detected by extended screening of working‐age adults in Madrid (Spain)32
Issue Information31
International disease burden of acute viral hepatitis among adolescents and young adults: An observational study29
Kinetics of quantitative hepatitis B surface antigen in patients with rheumatic disease and chronic hepatitis B receiving biologic agents27
23
Issue Information22
Baseline Alpha‐Fetoprotein Elevation and the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B: A Multicentre Cohort Study21
Evaluating the renal safety of tenofovir disoproxil fumarate in hepatitis B patients without chronic kidney disease21
Hepatitis A occurrence and outbreaks in Europe over the past two decades: A systematic review20
The role of serum sphingolipids as potential biomarkers of non‐response to direct acting antiviral therapy in chronic hepatitis C virus infection20
Hepatitis E Infection in Immunocompromised Patients Previously Treated With Rituximab20
20
Persistence of immunity against hepatitis A in Brazilian children vaccinated with a single dose of inactivated virus vaccine19
Investigating rates and risk factors for hepatitis C virus reinfection in people receiving antiviral treatment in England19
Cost‐effectiveness analysis of an active search to retrieve HCV patients lost to follow‐up (RELINK‐C strategy) and the impact of COVID‐1918
Falling treatment uptake in the hepatitis C care cascade is a growing threat to achieving elimination18
Serum HBV RNA predicts HBeAg clearance and seroconversion in patients with chronic hepatitis B treated with nucleos(t)ide analogues18
0.15301394462585